Submitted by Jorge Silva (jorgelmsilva@ufrrj.br) on 2018-10-16T18:19:32Z No. of bitstreams: 1 2013 - Gabriela Ferreira de Oliveira.pdf: 1149006 bytes, checksum: e5df0fd5e246ea685fd7bb50c7ab42d5 (MD5) / Made available in DSpace on 2018-10-16T18:19:32Z (GMT). No. of bitstreams: 1 2013 - Gabriela Ferreira de Oliveira.pdf: 1149006 bytes, checksum: e5df0fd5e246ea685fd7bb50c7ab42d5 (MD5) Previous issue date: 2013-08-12 / Sodium is the major electrolyte of the extra cellular space, essential for the control of plasma osmolality and blood pressure. In addition, sodium is the only mineral for which there is a defined appetite. For sodium homeostasis and for the regulation of extra cellular fluid, the reported physiological systems include the renin angiotensin aldosterone system, atrial natriuretic peptide and oxytocin. In mice the feeding behavior of sodium is well established and the central inhibition of sodium appetite has been demonstrated. However, in some domestic species, especially in horses, subject of this study, this behavior has not yet been clarified. This study aimed to evaluate the clinical and hematological effects, beyond the assessment of fluid and electrolyte balance and feeding behavior of fluids after the central administration of enalaprilat in horses experimentally dehydrated. Six adult, gelding horses, were used. The animals were subjected to water and food restriction for 72 hours prior the study, associated with the administration of three doses of furosemide in the first 24 hours. After the 72 hours fasting, the animals were divided into two experimental groups. The first group was called Control Group (CG) and the second, Treaty Group (TG). The animals of TG received 2.75 mg/animal of enalaprilat by intracarotideal route. After administration of enalaprilat, the animals had free access to water and hypertonic saline solution (1.8% of NaCl), with ingested volumes monitored. All animals were submitted to a regular and periodical physical examination, measured blood pressure and collected blood samples every 12 hours until the administration of enalaprilat, to evaluate the effects of dehydration; and 30, 60, 120, 180 minutes and 24 hours after administration, to evaluate the drug effects. Weight loss was the parameter that best reflected dehydration, which was estimated at 10.5% at the end of 72 hours of food and water restriction. When the animals had free access to water and saline, we observed a higher total water consumption in TG (13.7 ? 12 L) than in the CG (9.1 ? 7.9 L), with no significant difference between groups (p = 0.3522). There was no significant difference between GC and GT in clinical and hematological parameters, in all moments evaluated. Evaluating the sodium appetite, as evidenced by the ratio between salt intake and the amount of fluid consumed, it was observed that the TG showed lower sodium appetite than the CG (p = 0 0396), observed 120 minutes after the central administration of enalaprilat, demonstrating the centrally action of ACE inhibitor (enalaprilat) in inhibition of sodium appetite in horses. / O s?dio ? o principal eletr?lito do espa?o extracelular, fundamental para o controle da osmolaridade plasm?tica e press?o arterial, al?m de ser o ?nico mineral para qual existe um apetite claramente definido. Para a homeostase do s?dio e do fluido extracelular, os sistemas fisiol?gicos relatados incluem o sistema renina angiotensina aldosterona (SRAA), pept?deo natriur?tico atrial (ANP) e ocitocina (OT). O comportamento ingestivo de s?dio em ratos j? est? bem estabelecido e a inibi??o central do apetite por s?dio j? foi demonstrada. Por?m, em algumas esp?cies dom?sticas, especialmente nos equinos, tema deste trabalho, este comportamento ainda n?o foi esclarecido. O objetivo deste trabalho foi avaliar os efeitos cl?nicos e hematol?gicos, al?m da avalia??o do equil?brio hidroeletrol?tico e do comportamento ingestivo de l?quidos ap?s a administra??o central de enalaprilato em equinos experimentalmente desidratados. Foram utilizados seis equinos adultos, machos, castrados, que permaneceram em jejum h?drico e alimentar por 72 horas, associado ? administra??o de furosemida. Ap?s 72 horas de jejum, os animais foram divididos em dois grupos experimentais, o Grupo Controle (GC) e o Grupo Tratado (GT), que recebeu 2,75 mg/animal de enalaprilato por via intracarot?dea. Ap?s, os animais tiveram livre acesso a ?gua e a solu??o salina hipert?nica (1,8% de NaCl). Os animais foram avaliados atrav?s de exame cl?nico, a cada 12 horas durante as 72 horas de jejum e 30, 60, 120, 180 minutos e 24 horas ap?s o Enalaprilato. Foram avaliados o peso corporal, a quantidade de l?quidos ingeridos, a press?o arterial m?dia, par?metros bioqu?micos e eletrol?ticos sangu?neos. A perda de peso corporal foi o par?metro que melhor refletiu a desidrata??o, estimada em 10,5% ao final de 72 horas de jejum. Com o restabelecimento do acesso ? ?gua e solu??o salina, observou-se maior consumo total de ?gua no GT (13,7 ? 12 L) que no GC (9,1 ? 7,9 L), sem diferen?a significativa entre os grupos (p = 0,3522). N?o houve diferen?a significativa nos par?metros cl?nicos e hematol?gicos avaliados entre o GC e o GT. O apetite por s?dio foi reduzido significativamente (p = 0, 0396) no GT comparado ao GC, evidenciado 120 minutos ap?s a administra??o do enalaprilato, demonstrando a a??o central do inibidor de ECA (Enalaprilato) na inibi??o do apetite por s?dio em equinos.

Submitted by Diogo Misoguti (diogo.misoguti@gmail.com) on 2016-06-29T12:59:34Z No. of bitstreams: 1 cp118956.pdf: 11152798 bytes, checksum: 413c607598471e1abd0db7c49883c8ac (MD5) / Approved for entry into archive by Diogo Misoguti (diogo.misoguti@gmail.com) on 2016-06-29T13:00:23Z (GMT) No. of bitstreams: 1 cp118956.pdf: 11152798 bytes, checksum: 413c607598471e1abd0db7c49883c8ac (MD5) / Made available in DSpace on 2016-06-29T13:00:23Z (GMT). No. of bitstreams: 1 cp118956.pdf: 11152798 bytes, checksum: 413c607598471e1abd0db7c49883c8ac (MD5) Previous issue date: 2009 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) / Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) / Com o crescente aumento da prevalência mundial de diabetes mellitus, tem-se buscado modelos experimentais para melhor compreensão de sua fisiopatologia e tratamento que atendam de maneira mais adequada à preservação de células beta, proteção de órgãos-alvo e atenuação da aterosclerose. Objetivos: Desenvolver modelo experimental de diabetes mellitus tipo 2 induzido por meio de dieta, e utilizá-lo para examinar os efeitos de um inibidor da enzima conversora de angiotensina (IECA) e de um bloqueador do receptor de angiotensina (BRA) na proteção de órgãos-alvo. Métodos: Coelhos machos Nova Zelândia (n=49) receberam dieta acrescida de banha (10%), sacarose (40%) durante todo o protocolo do estudo além de colesterol (0,5% nos três primeiros meses e 0,1% nos meses subseqüentes). Os animais receberam aleatoriamente: apenas a dieta sem fármacos (G1), olmesartana 5 mg (G2), quinapril 30 mg (G3), ou a combinação de ambos (G4), acrescidos à mesma dieta por seis meses. Foram analisados lípides, frutosamina, glicose e insulina em jejum com cálculo dos índices para resistência à insulina e função de células beta pancreáticas. Foram ainda examinadas as áreas sob as curvas de insulina e glicose, após infusão de glicose intraperitoneal. Angiofluoresceinografias e análises histopatológicas avaliaram lesões em órgãos-alvo. Resultados: Os coelhos ganharam peso, e houve aumento dos níveis de glicose, colesterol total, LDL-C e triglicérides e redução do HDL-C (p <0,05 vs. basal). A frutosamina e o HOMA-IR se elevaram, enquanto houve redução do HOMA-β (p <0,05 vs. basal). Sinais precoces de retinopatia diabética foram observados a partir do terceiro mês, progredindo até o final do experimento (p<0,0005). Lesões ateroscleróticas em aorta, esteatofibrose hepática e infiltrado glomerular de macrófagos constituíram os principais achados histomorfológicos. O bloqueio do sistema renina-angiotensina modificou favoravelmente a glicemia e o HOMA-β (p<0,05) e houve atenuação do número e grau dos microaneurismas pelo tratamento com BRA isoladamente ou combinado com IECA (p<0,05 vs. G1). Conclusões: Nosso modelo reproduziu várias características glucometabólicas do diabetes mellitus tipo 2 humanóide, incluindo déficit de secreção e resistência à insulina. O bloqueio do sistema renina-angiotensina atenuou algumas alterações bioquímicas e as lesões microvasculares em retina. / With the increasing prevalence of diabetes mellitus worldwide, new experimental models are required to better understand the pathophysiology of this disease and to offer therapeutic options that can preserve pancreatic beta-cells, protect target organs and attenuate atherosclerosis. Objective: The aims of this study were to develop an experimental model of type 2 diabetes mellitus induced by diet and assess on this model the effects of an angiotensin-converting enzyme inhibitor (ACEI) and an antagonist of the angiotensin II type1 receptor (AT1R) on target organ protection. Methods: New Zealand male white rabbits (n=49) were fed high-fat/high-sucrose (10/40%) during the study protocol and cholesterol-enriched diet (0.5% in the first three months followed by 0.1% until the end of the study). These animals were randomized to receive: diet alone (G1), olmesartan 5 mg (G2), quinapril 30mg (G3), or combination of both drugs (G4), added to the same diet for six months. Fasting lipids, fructosamine, glucose and insulin, with calculation of insulin resistance and beta-cell function indexes were evaluated. The areas under the curves for glucose and insulin were obtained after intraperitoneal glucose bolus injection. Fluorescein angiography and histopathological analyses were performed to assess target-organs lesions. Results: The animals gained weight, and there were increases in blood glucose, total cholesterol, LDL-C and triglycerides, and decrease in HDL-C (p<0.05 vs. baseline). Fructosamine levels and the homeostasis model assessment of insulin resistance (HOMA-IR) were increased, while there was a reduction in the HOMA-β (p<0.05 vs. baseline). Early clinical features of diabetic retinopathy were seen since the third month, progressing up to the end of the experiment (p<0.0005). Aortic atherosclerosis, hepatic steatofibrosis and glomerular macrophage infiltration were the main histomorphologic findings of this study. The renin-angiotensin system (RAS) blockade favorably modified blood glucose and the HOMA- β (p<0.05) and promoted attenuation of the number and grade of microaneurysms in retina in the group of animals receiving AT1R antagonist or combined therapy with the ACEI (p<0.05 vs. G1). Conclusion: Our model reproduced several glucometabolic characteristics of humanoid type 2 diabetes, including decreased insulin secretion and insulin resistance. The RAS blockade attenuated some biochemical abnormalities and the diabetic retinopathy. / FAPESP: 07/51058-8